Evaxion Biotech A/S(EVAX)

$3.00—Earnings in 6d

Chart

Evaxion Biotech A/S(EVAX)

NASDAQ

$3.00—Earnings in 6d

Chart Studio

EVAX(EVAX)

EVAX

Overview Stream Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.01

Aug 13, 2026 · Reports before open

Revenue Estimate

$7M

FY2029E EPS$0.08

Analyst Sentiment

Wall St. Consensus

Buy

4 analysts·Low coverage

Score

4 Buy (100%)0 Hold (0%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

4100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$9.00

+200.5%

Consensus

$9.50

+217.2%

Bull

$10.00

+233.9%

12-Month Target Range4 analysts

$9.00$9.50$10.00

Current $3.00Consensus

Current Price

$3.00

Upside to Consensus

$6.50

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+329.07%

EPS—

FY2028

Rev+6.37%

EPS—

FY2029

Rev+202.23%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$5M	$23M	$24M	$73M	$29M
Low	$5M	$23M	$24M	$73M	$29M
High	$5M	$23M	$24M	$73M	$29M
EBITDA Avg	$-996,804	$-4M	$-5M	$-14M	$-6M
Low	$-996,804	$-4M	$-5M	$-14M	$-6M
High	$-996,804	$-4M	$-5M	$-14M	$-6M
EBIT Avg	$-1M	$-5M	$-5M	$-15M	$-6M
Low	$-1M	$-5M	$-5M	$-15M	$-6M
High	$-1M	$-5M	$-5M	$-15M	$-6M
Net Income Avg	$-160,203	$-192,243	$-192,243.5	$512,650	$-64,081
Low	$-160,203	$-192,243	$-2M	$512,650	$-64,081
High	$-160,203	$-192,243	$1M	$512,650	$-64,081
EPS Avg	$-0.03	$-0.03	$-0.03	$0.08	$-0.01
Low	$-0.03	$-0.03	$-0.24	$0.08	$-0.01
High	$-0.03	$-0.03	$0.18	$0.08	$-0.01
Analysts (Rev / EPS)	2 / 1	3 / 1	3 / 2	2 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$300,000	$206,000	—	—	—	—	—	—
Low	$300,000	$206,000	—	—	—	—	—	—
High	$300,000	$206,000	—	—	—	—	—	—
EBITDA Avg	$-56,780	$-38,988	—	—	—	—	—	—
Low	$-56,780	$-38,988	—	—	—	—	—	—
High	$-56,780	$-38,988	—	—	—	—	—	—
EBIT Avg	$-59,999	$-41,199	—	—	—	—	—	—
Low	$-59,999	$-41,199	—	—	—	—	—	—
High	$-59,999	$-41,199	—	—	—	—	—	—
Net Income Avg	$-83,402	$-83,402	$-3M	$-3M	$-4M	$-3M	$-90M	$-79M
Low	$-83,402	$-83,402	$-3M	$-3M	$-4M	$-3M	$-90M	$-79M
High	$-83,402	$-83,402	$-3M	$-3M	$-4M	$-3M	$-90M	$-79M
EPS Avg	$-0.01	$-0.01	$-0.37	$-0.39	$-0.42	$-0.33	$-10.75	$-9.50
Low	$-0.01	$-0.01	$-0.37	$-0.39	$-0.42	$-0.33	$-10.75	$-9.50
High	$-0.01	$-0.01	$-0.37	$-0.39	$-0.42	$-0.33	$-10.75	$-9.50
Analysts (Rev / EPS)	1 / 1	2 / 1	— / 1	— / 1	— / 1	— / 1	— / 1	— / 1

Earnings Surprises

Recent Analyst Actions

Mar 9, 2026Lake Street

Evaxion Biotech price target lowered to $9 from $11 at Lake Street

Target:$9.00

+192.2%from $3.08

Feb 19, 2026Maxim Group

Evaxion Biotech initiated with a Buy at Maxim

Target:$10.00

+207.7%from $3.25

Oct 20, 2025Lake Street

Evaxion Biotech price target raised to $11 from $6 at Lake Street

Target:$11.00

+54.1%from $7.14

Sep 25, 2025H.C. Wainwright

Evaxion Biotech price target raised to $16 from $14 at H.C. Wainwright

Target:$16.00

+253.2%from $4.53

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance